QIAGEN N.V. QGEN announced that it started shipping its new QIAstat-Dx Respiratory SARS-CoV-2 Panel test (which is to be sold as an in-vitro diagnostic or IVD) in the United States to help diagnose coronavirus-infected patients. The announcement came after a new policy of an Emergency Use Authorization (EUA) was declared by the FDA early this month. Notably, the company will submit the related EUA to the FDA this week.
Image: https://www.nasdaq.com
{iframe}https://www.nasdaq.com/articles/qiagen-releases-coronavirus-test-kit-in-us-on-new-fda-policy-2020-03-26{/iframe}